Computer Software Assurance vs. Traditional Computer System Validation

Traditional Computer System Validation (CSV) programs often apply broadly similar, document-heavy testing regardless of a system’s actual risk: the same volume of scripted test cases, the same level of screenshot evidence, whether the system touches a critical batch-release decision or a low-risk administrative task.

FDA's Computer Software Assurance (CSA) guidance describes a risk-based alternative: determine where additional rigor is genuinely warranted, and use assurance activities proportionate to that risk elsewhere. Source

What actually changes

• Test evidence shifts from exhaustive scripted protocols to evidence proportionate to risk — sometimes a recorded unscripted test with a brief note is sufficient for a low-risk function.
• Effort is concentrated on the functions that could affect product quality, patient safety, or record integrity, not spread evenly across every feature.
• Vendor-supplied testing and documentation can be leveraged, rather than independently re-proving functionality the vendor already tested, when appropriately justified.

What does not change

• The requirement that the organization can demonstrate the system performs its intended use.
• Part 11 expectations for the electronic records and signatures the system produces.
• The need for a documented rationale — CSA replaces uniform maximum rigor with a documented, risk-based decision, not with no decision at all.

A common misreading

Treating CSA as "less work" without a genuine risk assessment behind it is a misapplication of the guidance, not an application of it. The guidance describes a method for deciding how much assurance is enough — it does not itself lower the bar for high-risk systems.

Questions to ask when moving from CSV to CSA

• Have we actually documented a risk assessment for this system, or just decided informally to test less?
• Which functions of this system could affect product quality, patient safety, or record integrity?
• What evidence would we show an investigator to justify the level of testing we chose?
• Are we leveraging vendor testing appropriately, with a documented basis, or simply skipping verification?